SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRobert Walters Regulatory News (RWA)

Share Price Information for Robert Walters (RWA)

Share Price is delayed by 15 minutes
Get Live Data
85.00    1.00 (1.19%)
Bid:
84.00
Ask:
89.20
Spread: 5.20 (6.19%)
Market Cap: £55.91m
RWA Live PriceLast checked at - London Stock Exchange

Intraday Robert Walters Share Chart

Director/PDMR Shareholding

15 Mar 2017 17:15

RNS Number : 6075Z
Robert Walters PLC
15 March 2017
 

15 March 2017

ROBERT WALTERS PLC

(the "Company")

Directors' Shareholdings

The Company announces that the Executive Directors listed in the table below have deferred part of their respective annual bonuses for the financial year ended 31 December 2016 into ordinary shares of 20p each in the Company ("Ordinary Shares"), as required by the Company's Remuneration Policy. Accordingly, on 15 March 2017, the Directors were awarded a conditional right to receive Ordinary Shares, payable in equal tranches at the end of 31 December 2017 and 31 December 2018. The number of Ordinary Shares deferred and net of tax, as shown below, was calculated by reference to the price of £4.10 per share, being the purchase price on 15 March 2017.

Directors

Deferred Ordinary Shares

Robert Walters

29,390

Giles Daubeney

25,977

Alan Bannatyne

17,516

Total

72,883

 

The total of 72,883 Ordinary Shares were purchased by the Company on 15 March 2017 at the market price of £4.10 per share and will be held by the Company until the date of vesting, half at the end of 31 December 2017 and half at the end of 31 December 2018.

Vesting of deferred bonus shares

The Company was informed on 15 March 2017 of the following share transfers in ordinary shares of 20p each of the Company ("Ordinary Shares").

These dealings were pursuant to the vesting of awards deferred as part of their respective bonus for the financial year ended 31 December 2015 and as announced on 11 March 2016.

There has therefore been an increase in the overall shareholdings of each of the Directors as a result of these dealings and individual shareholdings before and after are set out below:

Director

Shareholding prior to this announcement

% holding in Company

Shareholding after this announcement

% holding in Company

 

Robert Walters

 

2,519,930

 

3.39

 

2,542,470

 

3.42

 

Giles Daubeney

 

1,807,242

 

2.43

 

1,826,034

 

2.46

 

Alan Bannatyne

 

424,247

 

0.57

 

438,008

 

0.59

 

2017 awards

The Company also announces that the following awards were made to certain Directors under the 2014 Robert Walters Performance Share Plan on 15 March 2017:

Director

No. of Robert Walters ordinary shares comprised in the award

Robert Walters

264,067

Giles Daubeney

234,269

Alan Bannatyne

161,216

Total

659,552

 

The awards, which were made in the form of options at nil cost, are subject to performance conditions. Vesting will normally not occur before three years have elapsed.

 

 

Robert Walters plc's issued share capital consists of 78,392,284 Ordinary Shares with voting rights. Robert Walters plc holds 4,074,000 Ordinary Shares in Treasury.

 Therefore, the total number of voting rights in Robert Walters plc is 74,318,284.

 The above figure of 74,318,284 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Robert Walters plc under the FSA's Disclosure and Transparency Rules.

 

 

Further information

Robert Walters plc

Robert Walters, Chief Executive

Alan Bannatyne, Chief Financial Officer

 

+44 20 7379 3333

Newgate Communications

Steffan Williams

Charlotte Coulson

+44 20 7680 6550

 

 

www.robertwalters.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFLDVSIELID
Date   Source Headline
14th May 20269:24 amRNSDirector/PDMR Shareholding
13th May 202610:40 amRNSDirector/PDMR Shareholding
5th May 202612:32 pmRNSDirector/PDMR Shareholding
1st May 202610:57 amRNSDirector/PDMR Shareholding
30th Apr 20263:16 pmRNSResult of AGM
30th Apr 202610:27 amRNSDirectorate change
28th Apr 202610:10 amRNSDirector/PDMR Shareholding
24th Apr 20269:34 amRNSDirector/PDMR Shareholding
17th Apr 20269:03 amRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSQ1 2026 Trading Update
14th Apr 20265:35 pmRNSBLOCK LISTING SIX MONTHLY RETURN
14th Apr 20263:46 pmRNSHolding(s) in Company
1st Apr 20266:12 pmRNSAnnual Financial Report
30th Mar 20267:00 amRNSBoard and Management Changes
27th Mar 20262:56 pmRNSHolding(s) in Company
27th Mar 20262:54 pmRNSHolding(s) in Company
23rd Mar 20269:21 amRNSHolding(s) in Company
17th Mar 202610:00 amRNSHolding(s) in Company
11th Mar 20267:00 amRNS2025 Full-Year Results
3rd Feb 20264:08 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSQ4 2025 Trading Update
18th Dec 20257:00 amRNSAppointment of Non-Executive Director
18th Nov 20255:10 pmRNSHolding(s) in Company
17th Nov 20255:00 pmRNSHolding(s) in Company
6th Nov 20258:55 amRNSBLOCK LISTING SIX-MONTHLY RETURN
14th Oct 20257:00 amRNSQ3 2025 Trading Update
11th Sep 20253:06 pmRNSHolding(s) in Company
8th Aug 20252:33 pmRNSHolding(s) in Company
31st Jul 20257:00 amRNS2025 Half-Year Results
23rd Jul 20254:56 pmRNSHolding(s) in Company
23rd Jul 20254:54 pmRNSHolding(s) in Company
15th Jul 20257:00 amRNSQ2 2025 Trading Update
9th Jun 20252:11 pmRNSHolding(s) in Company
4th Jun 20253:49 pmRNSHolding(s) in Company
2nd Jun 20252:50 pmRNSHolding(s) in Company
30th Apr 20254:09 pmRNSHolding(s) in Company
29th Apr 20252:59 pmRNSResult of 2025 Annual General Meeting
16th Apr 202512:06 pmRNSDirector/PDMR Shareholding
15th Apr 20257:00 amRNSQ1 2025 Trading Update
28th Mar 202511:00 amRNSAnnual Report and Annual General Meeting
12th Mar 202511:47 amRNSDirector/PDMR Shareholding
7th Mar 20259:28 amRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNS2024 full-year results
14th Feb 20257:00 amRNSHolding(s) in Company
16th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSQ4 2024 Trading Update
10th Jan 20254:22 pmRNSHolding(s) in Company
17th Dec 20244:32 pmRNSHolding(s) in Company
13th Dec 202411:06 amRNSHolding(s) in Company
11th Dec 20247:00 amRNSAppointment of Joint Corporate Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.